Sei Investments Co. Sells 150,848 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sei Investments Co. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 21.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 549,236 shares of the healthcare conglomerate’s stock after selling 150,848 shares during the quarter. Sei Investments Co.’s holdings in UnitedHealth Group were worth $279,711,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Macroview Investment Management LLC increased its holdings in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Delos Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $31,000. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth about $31,000. Finally, Signature Resources Capital Management LLC increased its holdings in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on UNH. TD Cowen upped their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Truist Financial upped their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Morgan Stanley upped their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $614.17.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

NYSE:UNH opened at $575.00 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock’s 50 day moving average price is $577.10 and its two-hundred day moving average price is $520.47. The firm has a market capitalization of $530.97 billion, a price-to-earnings ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the company earned $6.14 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.